BOSTON, May 2, 2018 /PRNewswire-PRWeb/ -- Connance, a healthcare leader in predictive analytics to personalize the
"Persisting layers of complexity in the healthcare financial environment continue feeding the explosive trend in denied claims. Denied claims create frustration and confusion for both patients and providers," said Venkat Raman, President and Chief Executive Officer of MedAssist. "Yes, quick resolution is important, but prevention is paramount. To achieve a systemic model of prevention, we need tools that can support our strategic modeling at scale. We selected Connance because their tools help us accelerate the timeline in which our hospital customers will increase cash, reduce days in AR, and access insights that will improve their contracting leverage with payers."
The Connance technology delivers guided, intelligent workflows powered by unique predictive analytics that assess and prioritize denied and underpaid claims by predicted cash value, instead of traditional age, balance and reason code variables. The technology activates both efficiency and increased productivity for MedAssist team members in their work to deliver a consistent, quality customer service experience.
"We are very excited to partner with MedAssist on this strategic initiative as they continue to create new value for their hospital customers in denial prevention and resolution." said Steve Levin, Chief Executive Officer of Connance. "In today's environment of shrinking reimbursements, with the rising cost to collect and constantly changing payer rules, managing denials has become a strategic imperative for survival. Partnering with forward-thinking organizations like MedAssist to streamline the denial and underpayment follow up is more important than ever."
To learn more about the Connance Denial and Underpayment Analytica solution, visit our website.
Subscribe to our Free Newsletters!
Birth Control Implant is a long-acting birth control contraceptive inserted into the arm. It is a ...
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...View All